- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6848 - Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Patent holdings for IPC class C12Q 1/6848
Total number of patents in this class: 806
10-year publication summary
|
13
|
34
|
45
|
81
|
120
|
89
|
118
|
131
|
74
|
68
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Natera, Inc. | 270 |
41 |
| Bio-Rad Laboratories, Inc. | 1602 |
28 |
| Life Technologies Corporation | 3127 |
21 |
| Illumina, Inc. | 2932 |
20 |
| Gen-Probe Incorporated | 983 |
18 |
| F. Hoffmann-La Roche AG | 7961 |
11 |
| President and Fellows of Harvard College | 5838 |
11 |
| Roche Molecular Systems, Inc. | 895 |
11 |
| Illumina Cambridge Limited | 681 |
9 |
| Roche Sequencing Solutions, Inc. | 582 |
9 |
| Integrated DNA Technologies, Inc. | 265 |
8 |
| Lumiradx UK Ltd | 58 |
8 |
| New England BioLabs, Inc. | 474 |
8 |
| Qiagen GmbH | 913 |
8 |
| Qiagen Sciences, LLC | 174 |
8 |
| Seegene, Inc. | 343 |
8 |
| Noul Co., Ltd. | 46 |
8 |
| Roche Diagnostics GmbH | 2733 |
7 |
| Pacific Biosciences of California, Inc. | 747 |
7 |
| Samplix ApS | 29 |
7 |
| Other owners | 550 |